More than half of U.S. adults suffer from cardiovascular disease, diabetes or obesity and a growing number experience all three. Plan sponsors can take action to address this increasingly complex chal...

Pregnant individuals require routine, dedicated care to ensure positive parental and fetal outcomes.

GLP-1 medications are FDA-approved specifically for weight loss for more than half the adult population of the United States. Plan sponsors can take action to manage weight and other cardiodiabesity-r...

A report from the Evernorth Research Institute offers insights that can help health plans optimize cancer care.

To create a strong pipeline of early career technology talent, and create equitable opportunities for underrepresented students, Evernorth has partnered with Access Point – a program designed to provi...

We are taking a thoughtful and comprehensive approach to assessing biosimilar options that considers several factors.

As a key resource during the COVID-19 pandemic, pharmacists have quickly been acknowledged as crucial contributors to patient care and better health outcomes.

As more people turn to diabetes medication to manage their weight, obesity has become a pressing concern for employers.

First-in-industry Digital Health Formulary is expanded to better enable people to find effective digital solutions that address their most pressing health care needs